Pregnannt Woman Photo, Courtesy of Pixabay

The U.S. market for gynecological devices is valued at almost $1.1 billion. Demographic factors, and age are just some of the driving forces that are facilitating change in the gynecology landscape.

Assisted reproduction technologies (ART) help women or couples conceive children. Most couples who use ART are affected by infertility, although ART can also be used to help lesbian couples or single women. Currently, an approximate 1.7% of all infants born in the United States every year are conceived using ART, according to the Centers for Disease Control and Prevention.

iData Research’s inquiry into the gynecological device market has found that the average age of couples seeking to have children has been steadily increasing throughout the last several decades. The average age of first birth in the U.S. has risen from 21.4 in 1970 to 26 in 2015. This trend is expected to continue for a variety of social and economic reasons. As couples get older, their fecundity often decreases, thus increasing the need for the use of assisted reproductive technologies. This is one of the contributing factors that is leading the overall gynecological device market to exceed $1.5 billion by 2026 in the United States.

In a statement from iData CEO, Kamran Zamanian,

“ART has improved over the past few years. Particularly in cryopreservation, there is an ongoing shift from slow freezing to vitrification, which is said to achieve better results. It is also a more expensive method, which will increase the value of the market. More recent advancements include innovations in the oocyte retrieval needles and the emergence of time-lapse technology. These developments aim to improve the handling of materials, thereby stimulating growth of the assisted reproduction procedural volume.”

Top Competitors in The Gynecological Devices Market

Hologic is leading the total U.S. gynecological device market. The company has an extensive product portfolio, encompassing the global endometrial ablation, mechanical uterine tissue removal, hysteroscope and fluid management device market segments.

In terms of revenue, Cooper Surgical leads the U.S. assisted reproduction technology device market in 2019 by a wide margin. The company has a substantial share in the oocyte retrieval needle and embryo transfer catheter market segments. This leap in revenue is due to their acquisition of Wallace Medical from Smiths Medical.

Other competitors include: Boston Scientific, Medtronic, Minerva Surgical, Merit Medical Systems, Laborie Medical, Ethicon, The Prometheus Group, Richard Wolf, Coloplast, Olympus, and Karl Storz.

For Further Market Information

More insights like this on the global market (20 Countries) can be found in a 3,650 page series of studies published by iData Research entitled the Gynecological Devices Market Analysis, Size, Trends | U.S. | 2020-2026 | MedSuite